β-Cyclodextrin-Based Nanosponges Functionalized with Drugs and Gold Nanoparticles

Area of Science:

• Nanotechnology
• Materials Science
• Pharmaceutical Sciences

Background:

• Drugs often have limitations hindering their therapeutic efficacy.
• Beta-cyclodextrin-based nanosponges (βCDNS) offer improved drug loading and stability.
• Gold nanoparticles (AuNPs) possess unique properties for therapeutic and diagnostic applications.

Purpose of the Study:

• To develop a novel nanomaterial combining βCDNS, drugs, and AuNPs.
• To enhance the loading capacity and stability of therapeutic agents.
• To create versatile systems for potential drug delivery applications.

Main Methods:

• Loading phenylethylamine (PhEA) and 2-amino-4-(4-chlorophenyl)-thiazole (AT) onto βCDNS.
• Functionalizing βCDNS-drug complexes with AuNPs to form βCDNS-PhEA-AuNP and βCDNS-AT-AuNP systems.
• Characterizing the nanomaterial formation and drug/AuNP loading using various techniques.

Main Results:

• Achieved high loading capacities for PhEA (90%) and AT (150%) in βCDNS, significantly exceeding native βCD.
• Demonstrated successful formation of βCDNS-drug-AuNP systems with immobilized AuNPs (85%).
• Confirmed exposed functional groups (SH and NH2) on drugs facilitated AuNP stabilization.

Conclusions:

• Developed novel βCDNS-PhEA-AuNP and βCDNS-AT-AuNP hybrid nanomaterials.
• These systems exhibit significantly enhanced drug loading capacity and stability.
• The versatile nanomaterials show promise for advanced therapeutic agent delivery.